DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 213 filers reported holding DENALI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,146,470 | +1002.4% | 49,760 | +1312.8% | 0.00% | – |
| Q2 2022 | $104,000 | -53.6% | 3,522 | -49.4% | 0.00% | – |
| Q1 2022 | $224,000 | -65.0% | 6,959 | -51.5% | 0.00% | -100.0% |
| Q4 2021 | $640,000 | +580.9% | 14,345 | +1102.4% | 0.00% | – |
| Q2 2021 | $94,000 | -6.9% | 1,193 | -79.3% | 0.00% | -100.0% |
| Q1 2020 | $101,000 | +197.1% | 5,756 | +161.6% | 0.00% | – |
| Q3 2019 | $34,000 | +1600.0% | 2,200 | +2100.0% | 0.00% | – |
| Q4 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $219,569,000 | 28.65% |
| ARCH Venture Management, LLC | 5,168,749 | $152,116,000 | 18.54% |
| Casdin Capital, LLC | 1,500,000 | $44,145,000 | 3.73% |
| Flagship Pioneering Inc. | 2,619,968 | $77,106,000 | 2.90% |
| Yiheng Capital Management, L.P. | 1,014,684 | $29,862,000 | 1.71% |
| SECTORAL ASSET MANAGEMENT INC | 202,100 | $5,948,000 | 1.20% |
| GILDER GAGNON HOWE & CO LLC | 1,956,820 | $57,589,000 | 1.03% |
| Artal Group S.A. | 600,000 | $17,658,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $158,024,002 | 0.87% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $283,000 | 0.69% |